313 related articles for article (PubMed ID: 26827160)
1. Design, synthesis and biological evaluation of monobactams as antibacterial agents against gram-negative bacteria.
Fu HG; Hu XX; Li CR; Li YH; Wang YX; Jiang JD; Bi CW; Tang S; You XF; Song DQ
Eur J Med Chem; 2016 Mar; 110():151-63. PubMed ID: 26827160
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and biological evaluation of C(4) substituted monobactams as antibacterial agents against multidrug-resistant Gram-negative bacteria.
Kou Q; Wang T; Zou F; Zhang S; Chen Q; Yang Y
Eur J Med Chem; 2018 May; 151():98-109. PubMed ID: 29605810
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and antibacterial evaluation against resistant Gram-negative bacteria of monobactams bearing various substituents on oxime residue.
Li ZW; Lu X; Wang YX; Hu XX; Fu HG; Gao LM; You XF; Tang S; Song DQ
Bioorg Chem; 2020 Jan; 94():103487. PubMed ID: 31831161
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and antibacterial evaluation of new monobactams.
Thu ZM; Sun J; Ji J; He L; Ji J; Iqbal Z; Myo KK; Gao Y; Zhai L; Mu Y; Tang D; Vidari G; Yang H; Yang Z
Bioorg Med Chem Lett; 2021 May; 39():127878. PubMed ID: 33636305
[TBL] [Abstract][Full Text] [Related]
5. Discovery of Novel Pyridone-Conjugated Monosulfactams as Potent and Broad-Spectrum Antibiotics for Multidrug-Resistant Gram-Negative Infections.
Tan L; Tao Y; Wang T; Zou F; Zhang S; Kou Q; Niu A; Chen Q; Chu W; Chen X; Wang H; Yang Y
J Med Chem; 2017 Apr; 60(7):2669-2684. PubMed ID: 28287720
[TBL] [Abstract][Full Text] [Related]
6. Pyridone-conjugated monobactam antibiotics with gram-negative activity.
Brown MF; Mitton-Fry MJ; Arcari JT; Barham R; Casavant J; Gerstenberger BS; Han S; Hardink JR; Harris TM; Hoang T; Huband MD; Lall MS; Lemmon MM; Li C; Lin J; McCurdy SP; McElroy E; McPherson C; Marr ES; Mueller JP; Mullins L; Nikitenko AA; Noe MC; Penzien J; Plummer MS; Schuff BP; Shanmugasundaram V; Starr JT; Sun J; Tomaras A; Young JA; Zaniewski RP
J Med Chem; 2013 Jul; 56(13):5541-52. PubMed ID: 23755848
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of the siderophore monosulfactam BAL30072 against contemporary Gram-negative pathogens from New York City, including multidrug-resistant isolates.
Landman D; Singh M; El-Imad B; Miller E; Win T; Quale J
Int J Antimicrob Agents; 2014 Jun; 43(6):527-32. PubMed ID: 24796217
[TBL] [Abstract][Full Text] [Related]
8. Novel monobactams utilizing a siderophore uptake mechanism for the treatment of gram-negative infections.
Mitton-Fry MJ; Arcari JT; Brown MF; Casavant JM; Finegan SM; Flanagan ME; Gao H; George DM; Gerstenberger BS; Han S; Hardink JR; Harris TM; Hoang T; Huband MD; Irvine R; Lall MS; Megan Lemmon M; Li C; Lin J; McCurdy SP; Mueller JP; Mullins L; Niosi M; Noe MC; Pattavina D; Penzien J; Plummer MS; Risley H; Schuff BP; Shanmugasundaram V; Starr JT; Sun J; Winton J; Young JA
Bioorg Med Chem Lett; 2012 Sep; 22(18):5989-94. PubMed ID: 22892121
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity of the novel monosulfactam BAL30072 alone and in combination with meropenem versus a diverse collection of important Gram-negative pathogens.
Hornsey M; Phee L; Stubbings W; Wareham DW
Int J Antimicrob Agents; 2013 Oct; 42(4):343-6. PubMed ID: 23837926
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and antibacterial activity of C-4 thio- and dithiocarbamate monobactam derivatives.
Cascio G; Lorenzi L; Caglio D; Manghisi E; Arcamone F; Guanti G; Satta G; Morandotti G; Sperning R
Farmaco; 1996 Mar; 51(3):189-96. PubMed ID: 8688141
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and antimicrobial properties of substituted 3-aminoxypropionyl and 3-aminoxy-(E)-2-methoxyiminopropionyl monobactams.
Balsamo A; Macchia B; Orlandini E; Rossello A; Macchia F; Broccali G; Fonio W
Farmaco; 1990 Jul; 45(7-8):879-88. PubMed ID: 2282121
[TBL] [Abstract][Full Text] [Related]
12. [Antibacterial activities of monobactams against fresh clinical isolates].
Deguchi K; Yokota N; Koguchi M; Nakane Y; Fukayama S; Nishimura Y; Oda S; Tanaka S; Kato M; Sato K
Jpn J Antibiot; 1988 Nov; 41(11):1600-22. PubMed ID: 3210297
[TBL] [Abstract][Full Text] [Related]
13. In vitro properties of BAL30072, a novel siderophore sulfactam with activity against multiresistant gram-negative bacilli.
Page MG; Dantier C; Desarbre E
Antimicrob Agents Chemother; 2010 Jun; 54(6):2291-302. PubMed ID: 20308379
[TBL] [Abstract][Full Text] [Related]
14. [BAL30072--an iron complexing beta lactam antibiotic against multidrug-resistant gram negative bacteria].
Schmitz J
Pharm Unserer Zeit; 2011 Mar; 40(2):98-9. PubMed ID: 21630531
[No Abstract] [Full Text] [Related]
15. Synthesis and in vitro antibacterial activity of a new series of monobactam derivatives.
Valcavi U; Aveta R; Brandt A; Corsi GB; Bosone E; Farina P; Guazzi G
Farmaco Sci; 1988 Jun; 43(6):559-66. PubMed ID: 3208898
[TBL] [Abstract][Full Text] [Related]
16. Antibacterial and antibiotic-resistance modifying activity of the extracts and compounds from Nauclea pobeguinii against Gram-negative multi-drug resistant phenotypes.
Seukep JA; Sandjo LP; Ngadjui BT; Kuete V
BMC Complement Altern Med; 2016 Jul; 16():193. PubMed ID: 27386848
[TBL] [Abstract][Full Text] [Related]
17. Preparation and antibiotic activity of monobactam analogues of nocardicins.
Gerardin-Charbonnier C; Auberger S; Molina L; Achilefu S; Manresa MA; Vinardell P; Infante MR; Selve C
Prep Biochem Biotechnol; 1999 Aug; 29(3):257-72. PubMed ID: 10431930
[TBL] [Abstract][Full Text] [Related]
18. Ebselen bearing polar functionality: Identification of potent antibacterial agents against multidrug-resistant Gram-negative bacteria.
Chen C; Yang K
Bioorg Chem; 2019 Dec; 93():103286. PubMed ID: 31585265
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and structure-activity relationship of novel bisindole amidines active against MDR Gram-positive and Gram-negative bacteria.
Liu Y; Hu X; Wu Y; Zhang W; Chen X; You X; Hu L
Eur J Med Chem; 2018 Apr; 150():771-782. PubMed ID: 29604581
[TBL] [Abstract][Full Text] [Related]
20. Conjugation of Aztreonam, a Synthetic Monocyclic β-Lactam Antibiotic, to a Siderophore Mimetic Significantly Expands Activity Against Gram-Negative Bacteria.
Liu R; Miller PA; Miller MJ
ACS Infect Dis; 2021 Nov; 7(11):2979-2986. PubMed ID: 34668698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
